Conventional Step-Up Versus Infliximab Monotherapy in Patients With Active Moderate to Severe Ulcerative Colitis. A Randomized, Open Label, Prospective, Multicenter Study

Trial Profile

Conventional Step-Up Versus Infliximab Monotherapy in Patients With Active Moderate to Severe Ulcerative Colitis. A Randomized, Open Label, Prospective, Multicenter Study

Discontinued
Phase of Trial: Phase III

Latest Information Update: 18 Apr 2017

At a glance

  • Drugs Prednisolone (Primary) ; Azathioprine; Infliximab; Mesalazine
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Acronyms MUNIX
  • Sponsors Merck & Co; Schering-Plough
  • Most Recent Events

    • 18 Apr 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 18 Apr 2012 Actual patient number is 28 according to ClinicalTrials.gov.
    • 10 Apr 2012 Actual end date (Mar 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top